Pharmacological treatment options for mast cell activation disease
Crossref DOI link: https://doi.org/10.1007/s00210-016-1247-1
Published Online: 2016-04-30
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Molderings, Gerhard J.
Haenisch, Britta
Brettner, Stefan
Homann, Jürgen
Menzen, Markus
Dumoulin, Franz Ludwig
Panse, Jens
Butterfield, Joseph
Afrin, Lawrence B.
License valid from 2016-04-30